Recent Blog Articles
A new targeted treatment for early-stage breast cancer?
What is neurodiversity?
Thinking about holiday gatherings? Harvard Health experts weigh in
Time to stock up on zinc?
Recent study shows more complications with alternative prostate biopsy method
Walnuts: A worthy addition to your daily diet?
What it takes to achieve world-changing scientific breakthroughs
Do weighted blankets help with insomnia?
Careful! Health news headlines can be deceiving
Why is topical vitamin C important for skin health?
Steve Jobs's cancer
Pancreatic neuroendocrine tumors are becoming more common (the bad news) and also more treatable (the good news).
Pancreatic cancer is a dreaded and especially deadly type of cancer. About 44,000 Americans will be diagnosed with pancreatic cancer this year, accounting for approximately 3% of all cancer diagnoses. Unless some dramatic breakthroughs in treatment occur, fewer than 3,000 will be alive in five years.
To continue reading this article, you must log in.
Subscribe to Harvard Health Online for immediate access to health news and information from Harvard Medical School.
- Research health conditions
- Check your symptoms
- Prepare for a doctor's visit or test
- Find the best treatments and procedures for you
- Explore options for better nutrition and exercise
I'd like to receive access to Harvard Health Online for only $4.99 a month.Sign Me Up
Already a member? Login ».
As a service to our readers, Harvard Health Publishing provides access to our library of archived content. Please note the date of last review or update on all articles. No content on this site, regardless of date, should ever be used as a substitute for direct medical advice from your doctor or other qualified clinician.
Free Healthbeat Signup
Get the latest in health news delivered to your inbox!